For help on how to get the results you want, see our search tips.
279 results
Referral type
Article 29(4) referrals Remove Article 29(4) referrals filter
Article 33 Remove Article 33 filter
Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter
Article 30 referrals Remove Article 30 referrals filter
Medicine
Referrals Remove Referrals filter
-
List item
Referral: Clenil and associated names
beclometasone dipropionate, associated names: Becloneb, Beclospin and Sanasthmax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/09/2016, EC decision date: 11/11/2016, Last updated: 18/11/2016 -
List item
Referral: Durogesic and associated names
fentanyl, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 19/10/2016 -
List item
Referral: Diclofenac epolamine 50 mg tablets
diclofenac, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 22/09/2016, Last updated: 10/10/2016 -
List item
Referral: CattleMarker IBR Inactivated
Infectious bovine rhinotracheitis vaccine (inactivated), Article 33
Status: European Commission final decision, opinion/position date: 17/03/2016, EC decision date: 10/06/2016, Last updated: 19/07/2016 -
List item
Referral: Novantrone and associated names
mitoxantrone, associated names: Elsep, Ralenova, Article 30 referrals
Status: European Commission final decision, opinion/position date: 28/04/2016, EC decision date: 24/06/2016, Last updated: 05/07/2016 -
List item
Referral: Cymevene
ganciclovir, associated names: Cymevan, Citovirax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 21/06/2016 -
List item
Referral: Amoxil
amoxicillin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 20/08/2015, Last updated: 19/05/2016 -
List item
Referral: Tobramycin VVB and associated names
tobramycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/01/2015, EC decision date: 04/04/2016, Last updated: 04/05/2016 -
List item
Referral: Solamocta 697 mg/g powder for use in drinking water for chickens, ducks and turkeys
Amoxicillin trihydrate, Article 33
Status: European Commission final decision, opinion/position date: 04/11/2015, EC decision date: 07/01/2016, Last updated: 05/02/2016 -
List item
Referral: Gutal
zinc oxide, Article 33
Status: European Commission final decision, opinion/position date: 06/05/2015, EC decision date: 22/10/2015, Last updated: 26/11/2015 -
List item
Referral: Coglapix suspension for injection for pigs
inactivated porcine actinobacillosis vaccine, Article 33
Status: European Commission final decision, opinion/position date: 03/06/2015, EC decision date: 28/08/2015, Last updated: 02/10/2015 -
List item
Referral: Merisone and associated names
tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, EC decision date: 25/06/2015, Last updated: 28/07/2015 -
List item
Referral: Myoson and associated names
tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, Last updated: 28/07/2015 -
List item
Referral: Ikorel and Dancor
nicorandil, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/03/2015, EC decision date: 05/06/2015, Last updated: 30/06/2015 -
List item
Referral: Plendil and associated names
felodipine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 16/12/2014, Last updated: 30/03/2015 -
List item
Referral: Nasonex
mometasone furoate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 19/01/2015, Last updated: 03/02/2015 -
List item
Referral: Seasonique and associated names
levonorgestrel, ethinylestradiol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 12/01/2015, Last updated: 29/01/2015 -
List item
Referral: EMLA cream and associated names
lidocaine, prilocaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/09/2014, EC decision date: 28/11/2014, Last updated: 15/01/2015 -
List item
Referral: Seroquel / Seroquel XR and associated names
quetiapine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 09/09/2014 -
List item
Referral: Dexamed and associated names
dexamfetamine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 02/09/2014 -
List item
Referral: Fiprex
fipronil, Article 33
Status: European Commission final decision, opinion/position date: 09/04/2014, EC decision date: 14/07/2014, Last updated: 14/08/2014 -
List item
Referral: Porcimectin Injection and its associated names
ivermectin, associated names: Porcimec P, Article 33
Status: European Commission final decision, opinion/position date: 12/06/2002, EC decision date: 12/09/2002, Last updated: 13/08/2014 -
List item
Referral: Bovimectin Injection and its associated names
ivermectin, associated names: Bovimec B, Article 33
Status: European Commission final decision, opinion/position date: 12/06/2002, EC decision date: 19/09/2002, Last updated: 13/08/2014 -
List item
Referral: Cobactan IV 4.5% powder and solvent for solution for injection and its associated names
cefquinome, associated names: Cobactan, Cobactan Vet., Cobactan 4.5%, Cobactan IV IM 4.5%, Cobactan IV 4.5% A.U.V., Cephaguard IV IM 4.5%, Article 33
Status: European Commission final decision, opinion/position date: 17/05/2006, EC decision date: 21/08/2006, Last updated: 12/08/2014 -
List item
Referral: Orbax
orbifloxacin, Article 33
Status: European Commission final decision, opinion/position date: 15/01/2003, EC decision date: 16/04/2003, Last updated: 11/08/2014